We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Accrol Group Holdings Plc | LSE:ACRL | London | Ordinary Share | GB00BZ6VT592 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 38.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/2/2021 15:26 | Anyone considered that the worldwide price of pulp has started to increase recently ? Will be interesting to see how Accrol will get price increases from the likes of Lidl / Aldi......... | jk46664 | |
19/2/2021 06:01 | its painful but you would think a bigger plant would lead to increased economies of scale | arbus5000 | |
19/2/2021 00:34 | £20M admin costs p.a.!! :-o | cyberbub | |
19/2/2021 00:23 | Not that impressed to see directors all selling chunky amounts of shares recently. | cyberbub | |
19/2/2021 00:18 | SCSW says the new mill will cost £40M, how will that be financed - 100% debt? | cyberbub | |
05/2/2021 12:20 | I bought a few more last week - average now around 67. I almost sold out as the share price had got close to my stop loss (news years resolution, set and use stop losses). Hopefully yesterday was the bottom. Latest version of SCSW alludes to the new mill, says payback would be 3 or so years which would be great if true. | dr biotech | |
05/2/2021 11:38 | What a pertectly timed top up of mine this morning. these guys are absolutely thowing it out wilh all lines running, ive not known them to be so busy, The former LTC site is converting far more than it was pre Tejani, at 58p it was far too cheap, they must be coining it in, too soon for an update but ill await it with anticipation. | stevieweebie2 | |
05/2/2021 11:01 | Big volume cleared. Seller finished imv | tole | |
05/2/2021 10:31 | Retrace done? First tick up for a while | tole | |
01/2/2021 13:51 | Although relevant... it's old news now. We've had the results so expect a pull back which is what where seeing now. It won't be long before people are buying again. | leadersoffice | |
30/1/2021 09:25 | Seems to be a big leap in pre-tax profits !!! | john09 | |
30/1/2021 08:11 | https://masterinvest | tole | |
20/1/2021 15:12 | Yes in the podcast and the Q and A session.Very informative. | geraldus | |
20/1/2021 14:40 | was it the end of the podcast, I missed the end.? | stevieweebie2 | |
20/1/2021 14:40 | Hi Gerald, where did you get that from? | stevieweebie2 | |
19/1/2021 23:06 | More acquisitions and a mill.Will be passing the hat around again no doubt. | geraldus | |
18/1/2021 13:23 | Any views to share from watching the Podcast: ??? | bb123 | |
18/1/2021 12:19 | Here's the ACRL presentation with Q&A from Friday (15.1.21) Video: Podcast: | tomps2 | |
14/1/2021 10:33 | ACRL results webinar tomorrow on piworld, when you can ask any questions. Register here: | tomps2 | |
14/1/2021 10:14 | Directors Talk - 14/1/21: Accrol Group Holdings Growth will be multifaceted say Zeus Capital (Analyst Interview) Accrol Group Holdings plc (LON:ACRL) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. With the company producing is half year trading update Mike talks us through the key drivers, talks about the potential for growth, changes to the forecast and how he views the company in terms of a valuation. | simon gordon | |
14/1/2021 07:21 | It looks like the selling after the results were the result of bosses selling enough shares to pay the tax on their share awards. | this_is_me | |
13/1/2021 18:30 | Moving in the right direction today. | leadersoffice | |
12/1/2021 13:36 | The 'Buy on the rumour sell on the news' syndrome. | this_is_me |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions